A phase 3 trial found that Eli Lilly's tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated ...

However people generally need to keep taking the medicine in order to maintain their weight loss. Mounjaro was recently approved by the SMC as a treatment for type 2 diabetes as it also helps ...

It is thought to be the first time the medicine has been listed as a contributing factor on a death certificate. Like all drugs, Mounjaro is not without side-effects. Yet speaking to MailOnline ...

A weight drug recently legalised in the UK contributed to the death of a 58-year-old nurse, according to a new report.

The most common side effects of the medicine are nausea, diarrhoea, vomiting, and constipation. The UK Government signed a landmark deal with Mounjaro manufacturer Lilly last month, investing £ ...

"Mounjaro was approved based on extensive assessment of the benefits and risks of the medicine, and we provide information about the benefits and risks of all our medicines to regulators around ...

Lilly said inventory decreases by wholesale distributors hurt sales of its diabetes drug Mounjaro and anti-obesity medicine Zepbound. Mounjaro sales more than doubled to $3.11 billion last quarter ...

The drug - in the form of its Mounjaro KwikPen device - was approved by the UK's ... Back in June, the Society for Acute Medicine warned that doctors were treating "increasing numbers" of patients ...

Novo said supply of Wegovy and Ozempic is in good shape after the drugs were removed from the FDA’s shortage list last week.